American National Red Cross Apheresis Plasma
Apheresis PF24RT24 Plasma was collected in a manner that compromises the sterility of the collection system.
Recall ended Sep 15, 2026. Still check yours.
Moderate risk
Taking it may cause temporary or medically reversible health problems. Serious harm is unlikely.
FDA Class II recall · How risk is rated
What happened
American National Red Cross Blood Services SW Region began a recall of Apheresis PF24RT24 Plasma on March 26, 2026, because the product was collected in a manner that compromises the sterility of the collection system. The FDA added the recall to its Enforcement Report and classified it on September 15, 2026.
Summary by Recall Canary from the FDA notice.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these product details with yours, then check the recall notice for any restrictions.
Apheresis PF24RT24 Plasma
Details
- Company began the recall
- Event ID
- 99579
- Company
- American National Red Cross Blood Services SW Region
- Hazard
- Sterility failure
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
All recalls from American National Red Cross Blood Services SW Region
